In transition-age patients with childhood-onset growth hormone deficiency (GHD), peak growth hormone (GH) response to the glucagon stimulation test (GST) appeared to be influenced more by the severity ...

Guardant Health, Inc. (NASDAQ:GH) and research collaborators have unveiled results from the largest study to date on circulating tumor DNA (ctDNA) testing in stage III colon cancer, presented at the ...

Guardant Health (NASDAQ:GH) shares turned lower on Tuesday after FDA staffers commented on its Shield blood test for colorectal cancer screening (CRC) ahead of an advisory committee meeting later this ...

Researchers are reporting the first scientific evidence that a hormone banned in sports can boost athletic performance. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

We are at a critical time and supporting science journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen scientific ...